» Articles » PMID: 39408909

Expression Profiling of Coding and Noncoding RNAs in the Endometrium of Patients with Endometriosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 16
PMID 39408909
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to identify differentially expressed lncRNAs (DElncRNAs) and mRNAs (DEmRNAs) in the endometrium of individuals with and without endometriosis (EMS) during the proliferative (P) and secretory (S) phases of the menstrual cycle. Tissues were obtained from 18 control (CT; P-phase [pCT], = 8; S-phase [sCT], = 13) and 23 EMS patients (P-phase [pEMS], = 13; S-phase [sEMS], = 12). DElncRNAs and DEmRNAs were analyzed using total RNA-sequencing. In P-phase, expression of and was significantly higher in EMS than control patients, that of while and was lower in EMS patients. In S-phase, expression of , , and was significantly increased in EMS patients, while that of and was lower. In addition, the expression of , , , and was similar to that of neighboring lncRNAs in both P- and S-phases. In contrast, and , respectively, were up- or downregulated in pEMS tissues. In sEMS, expression of and was increased, while expression of was reduced. Our findings on lncRNAs and mRNAs encourage not only exploration of the potential clinical applications of lncRNAs and mRNAs as prognostic or diagnostic biomarkers for EMS but also to gain valuable insights into its pathogenesis.

Citing Articles

Mapping Human Uterine Disorders Through Single-Cell Transcriptomics.

Boldu-Fernandez S, Lliberos C, Simon C, Mas A Cells. 2025; 14(3).

PMID: 39936948 PMC: 11817058. DOI: 10.3390/cells14030156.

References
1.
Wang Y, Nicholes K, Shih I . The Origin and Pathogenesis of Endometriosis. Annu Rev Pathol. 2019; 15:71-95. PMC: 7980953. DOI: 10.1146/annurev-pathmechdis-012419-032654. View

2.
Kumari P, Sharma I, Saha S, Srinivasan R, Sharma A . Promoter methylation status of key genes and its implications in the pathogenesis of endometriosis, endometrioid carcinoma of ovary and endometrioid endometrial cancer. J Cancer Res Ther. 2022; 18(Supplement):S328-S334. DOI: 10.4103/jcrt.JCRT_1704_20. View

3.
Wang Y, Ikeda J, Rahadiani N, Mamat S, Ueda Y, Tian T . Prognostic significance of elongator protein 3 expression in endometrioid adenocarcinoma. Oncol Lett. 2012; 3(1):25-29. PMC: 3362337. DOI: 10.3892/ol.2011.428. View

4.
Yang Y, Yang W . Epithelial-to-mesenchymal transition in the development of endometriosis. Oncotarget. 2017; 8(25):41679-41689. PMC: 5522315. DOI: 10.18632/oncotarget.16472. View

5.
Li L, Song X . The Working Modules of Long Noncoding RNAs in Cancer Cells. Adv Exp Med Biol. 2016; 927:49-67. DOI: 10.1007/978-981-10-1498-7_2. View